The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients
Terminated
- Conditions
- Asthma
- Registration Number
- NCT00575445
- Lead Sponsor
- Akron Children's Hospital
- Brief Summary
The purpose of this study is to determine if exhaled nitric oxide (eNO) levels will be increased in pediatric patients with uncontrolled asthma as determined by the Asthma Control Test (ACT). During the study the investigators will also examine if the combination of eNO and ACT will better predict asthma control that either tool alone when compared to a medical provider's assessment of the patient's asthma control.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Clinical diagnosis of asthma by pediatric pulmonologist
- Age 6-18 years
Read More
Exclusion Criteria
- Age <6 years or >18 years
- history of bronchopulmonary dysplasia
- history of cystic fibrosis
- history of primary ciliary dyskinesia
- current acute asthma exacerbation
- current acute viral upper respiratory infection
- recent ingestion of nitrate-rich foods
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Exhaled nitric oxide level One office visit
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Akron Children's Hospital
🇺🇸Akron, Ohio, United States